Unknown NA INTERVENTIONAL 1-arm NCT04295096

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Collection of Peripheral Blood Mononuclear Cells From Healthy Subjects for the Development of Cellular Immunotherapy Product

Sponsor: Jun Zhu

Conditions Healthy Subject

Interventions Peripheral blood mononuclear cell apheresis

Updated 8 times since 2020 Last updated: Jun 7, 2021 Started: Apr 1, 2020 Primary completion: Feb 29, 2024 Completion: Mar 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04295096, this NA trial focuses on Healthy Subject and remains ongoing. Sponsored by Jun Zhu, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Sep 2021 — Apr 2024 [monthly]

Recruiting NA
Jan 2021 — Sep 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Sep 2020 — Jan 2021 [monthly]

Recruiting NA
Jul 2020 — Sep 2020 [monthly]

Recruiting NA
Apr 2020 — Jul 2020 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jun Zhu
Nanjing Legend Biotech Co.

Data source: Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China